Please enjoy ARK's weekly newsletter curated by our thematic research team and designed to keep you engaged with disruptive innovation.
Not rendering correctly? View this email as a web page here.
The FDA Has Approved America’s First Gene-Editing Therapy—Casgevy, and More...
ARK • Disrupt
It's Your weekly innovation newsletter
It's Monday, December 11, 2023. Please enjoy ARK's weekly newsletter curated by our thematic research team and designed to keep you engaged with disruptive innovation.
The FDA Has Approved America’s First Gene-Editing Therapy—Casgevy
Last Friday, the Food and Drug Administration (FDA) approvedi the first gene-editing therapy in the US. Developed and manufactured by CRISPR Therapeutics and Vertex Pharmaceuticals, Casgevy will treat patients with severe Sickle Cell Disease (SCD).
SCD is a rare disease that inhibits red blood cells with sickle shapes from traveling through blood vessels and providing the body with oxygen. The disease currently impacts ~100,000ii people in the United States and ~20 millioniii worldwide. Casgevy targets the BC11A gene which, after birth, stops red blood cells from producing fetal hemoglobin, unless adult hemoglobin falters.
Casgevy’s approval is a major milestone for therapies that target and cure the root causes of disease. We look forwardiv to the next Prescription Drug User Fee Act (PDUFA) meeting on March 30, 2024v during which the FDA will discuss whether to approve Casgevy for another rare blood disease, beta-thalassemia (TDT).
Google Made Some Unforced Errors During Its Highly Anticipated Gemini Launch
By Frank Downing | @DowningARK Director of Research, Next Generation Internet
Last week, Google introduced Gemini,vi its latest suite of foundation models. Built from the ground up to be multi-modal—including images, audio, video, and text—Gemini purportedly is the first AI model to score higher than expert humans on the Massive Multitask Language Understanding (MMLU) benchmark, thanks to its better inherent reasoning and generation capabilities across various media.
Here’s the catch! To capture that headline, Google used different prompting techniques in comparing Gemini Ultra to GPT-4. Only when prompted by a special technique called “Chain-of-Thought@32 (Uncertainty-Routed),” which Google developed, did Gemini Ultra outperform both GPT-4 and expert humans. Based on the standard “5-shot” MMLU benchmark method described in Open-AI's paper, GPT-4 outperformed Gemini Ultra. In Google’s technical report,vii this important distinction became clear, as shown below.
Source: Google 2023.viii For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security or cryptocurrency. Past performance is not indicative of future results.
In our view, Google compared apples to oranges in declaring Gemini Ultra the superior model. Moreover, a videoix showcasing Gemini’s vision and reasoning capabilities had been editedx significantly: it did not include full prompts, nor did it delineate between the contribution to results of the model and the video editor.
Perhaps caused by Google’s marketing team, these blunders risk undercutting the credibility of DeepMind, Google’s formidable AI team. The engineers at DeepMind have contributed to many significant technical breakthroughs and “ah-ha” moments in AI over the years and seemingly would not want to blemish their record with this kind of deception. Perhaps Google has ceded too much power to marketing in response to competitive pressure from OpenAI in the monumental race toward AGI (Artificial General Intelligence)!
AMD Is Competing With Nvidia for Inference Workloads
Last week, AMD officially launchedxi its MI300X accelerator which, according to the company, outperforms Nvidia's H100 by a factor of 1.4x in inferencing Llama 2 70B. While that trails NVIDIA's next generation H200's 1.9x improvement over the H100, AMD is likely to price the MI300X significantly lower than both the H100 and H200. If AMD were to price the MI300X at $18-$19,000,xii and if H100s and H200s were to sell in the $25-$40,000xiii range, then not only would the MI300X offer better performance per dollar of capex than both the H100 and H200, as shown below, but it also could be accretive to AMD’s margins.
Source: ARK Investment Management LLC, 2023, based on data from Nvidia as of December 8, 2023. Forecasts are inherently limited and cannot be relied upon. For informational purposes only and should not be considered investment advice or a recommendation to buy, sell, or hold any particular security or cryptocurrency. Past performance is not indicative of future results.
AMD also touted the performance improvement in its open-source software ecosystem with support from Meta, OpenAI, and others. While AMD’s ROCm software is gaining traction, Nvidia’s software moat remains formidable. Highlightedxiv during Nvidia’s most recent earnings call, the TensorRT-LLM SDK (Software Development Kit) promises to boost LLM inferencing performance 2x on Nvidia hardware. Software can improve performance per dollar of capex on AI inferencing hardware significantly, as shown on the right side of the chart above. In our view, software will remain an important battleground for GPU providers as the applications built around LLMs drive demand for efficient compute.
Two weeks ago, the Institute for Intelligent Computing and Alibaba Group published an image-to-video model called Animate Anyone.xv The model transforms an input reference image and a pose sequence into a video. Unlike in previous image-to-video research, Animate Anyone introduced a feature extraction network called ReferenceNet that captures details from the original reference image in each video frame generated.
Trained on 5,000-character video clips, 340 dancing TikTok videos, and 500 fashion videos, and preserving image detail across multiple frames, Animate Anyone seems to outperform existing image-to-video generation methods in creating detailed, consistent, and continuous short form videos across a few genres. In our view, as the supply of user-generated content continues to boom, the algorithmic curation of entertainment will silo users even more narrowly into their own content microcosms, increasingly fragmenting viewership. Interestingly, The Verge reportedxvi that its editor had not seen any of TikTok’s top 10 videos for the year 2023.
As a result, shared entertainment—either online or in-person—could become even more valuable over time. Perhaps to the dismay of consumers, live sports, live music, and social gaming could continue to benefit from higher priced tickets and advertising.
[i] U.S. Food & Drug Administration. 2023. “FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease.
[ii] Centers for Disease Control and Addiction. 2023. “Data & Statistics on Sickle Cell Disease.”
[iii] National Heart, Lung, and Blood Institute. 2023. “What Is Sickle Cell Disease?” [iv] Urman, A. 2023. “The FDA AdComm Looks Promising For Exa-Cel.” ARK Disrupt. ARK Investment Management LLC.
[v] CRISPR Therapeutics. 2023. “CRISPR Therapeutics Announces Completion of FDA Advisory Committee Meeting for Exagamglogene Autotemcel (exa-cel) for Severe Sickle Cell Disease.”
[vi] Google Deep Mind. 2023. “Welcome to the Gemini Era.”
[vii] Google. 2023. “Gemini: A Family of Highly Capable Multimodal Models.”
[viii] Ibid.
[ix] Google. 2023. ”Hands-on with Gemini: Interacting with multimodal AI.” YouTube.
[x] Jones, A. 2023. “Fun fact: that viral-ish Gemini demo video is basically entirely fake.” X.
[xi] AMD. 2023. “Advancing AI.”
[xii] Patel, D. and Kostovic, A. 2023. “AMD AI Software Solved — MI300X Pricing, Performance, PyTorch 20.0, Flash Attention, OpenAI Triton.” Semianalysis. [xiii] Schreiner, M. 2023. “Nvidia's H100 GPU sells like hot cakes with high profit margins.” The Decoder.
[xv] Hu, L. et al. 2023. “Animate Anyone: Consistent and Controllable Image-to-Video Synthesis for Character Animation.”
[xvi] Sato, M. 2023. “TikTok’s biggest hits are videos you’ve probably never seen.” The Verge.
Fact of the Week
Last week, AMD officially launched its MI300X accelerator which, according to the company, outperforms Nvidia's H100 by a factor of 1.4x in inferencing Llama 2 70B.
This Newsletter is for informational purposes only and does not constitute, either explicitly or implicitly, any provision of services or products by ARK Investment Management LLC (“ARK”). Investors should determine for themselves whether a particular service or product is suitable for their investment needs or should seek such professional advice for their particular situation. All content is original and has been researched and produced by ARK unless otherwise stated therein. No part of the content may be reproduced in any form, or referred to in any other publication, without the express written permission of ARK. All statements made regarding companies, securities or other financial information contained in the content or articles relating to ARK are strictly beliefs and points of view held by ARK and are not endorsements of any company or security or recommendations to buy or sell any security. By visiting and/or otherwise using the ARK website in any way, you indicate that you understand and accept the terms of use as set forth on the website and agree to be bound by them. If you do not agree to the terms of use of the website, please do no access the website or any pages thereof. Any descriptions of, references to, or links to other products, publications or services does not constitute an endorsement, authorization, sponsorship by or affiliation with ARK with respect to any linked site or its sponsor, unless expressly stated by ARK. Any such information, products or sites have not necessarily been reviewed by ARK and are provided or maintained by third parties over whom ARK exercises no control. ARK expressly disclaims any responsibility for the content, the accuracy of the information, and/or quality of products or services provided by or advertised on these third-party sites. For full disclosures, click here.